Search

Karen C. Carlson

Examiner (ID: 14133, Phone: (571)272-0946 , Office: P/1656 )

Most Active Art Unit
1656
Art Unit(s)
1652, 1635, 1812, 1651, 1814, 1642, 1653, 1656, 1611, 1801
Total Applications
2193
Issued Applications
1462
Pending Applications
175
Abandoned Applications
558

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14406793 [patent_doc_number] => 20190169240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => DNA-BINDING PROTEIN USING PPR MOTIF, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/216617 [patent_app_country] => US [patent_app_date] => 2018-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 376 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16216617 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/216617
DNA-BINDING PROTEIN USING PPR MOTIF, AND USE THEREOF Dec 10, 2018 Abandoned
Array ( [id] => 18172846 [patent_doc_number] => 11572547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-07 [patent_title] => Fusion proteins for the detection of apoptosis [patent_app_type] => utility [patent_app_number] => 16/770551 [patent_app_country] => US [patent_app_date] => 2018-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 6314 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770551 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/770551
Fusion proteins for the detection of apoptosis Dec 5, 2018 Issued
Array ( [id] => 18134922 [patent_doc_number] => 11560578 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-24 [patent_title] => Neopinone isomerase and methods of using [patent_app_type] => utility [patent_app_number] => 16/770207 [patent_app_country] => US [patent_app_date] => 2018-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 38 [patent_no_of_words] => 23605 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770207 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/770207
Neopinone isomerase and methods of using Nov 28, 2018 Issued
Array ( [id] => 14043923 [patent_doc_number] => 20190078068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-14 [patent_title] => Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same [patent_app_type] => utility [patent_app_number] => 16/196411 [patent_app_country] => US [patent_app_date] => 2018-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16196411 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/196411
Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same Nov 19, 2018 Abandoned
Array ( [id] => 18369351 [patent_doc_number] => 11649509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-16 [patent_title] => Anastasis biosensor caspase tracker [patent_app_type] => utility [patent_app_number] => 16/763849 [patent_app_country] => US [patent_app_date] => 2018-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 8524 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763849 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/763849
Anastasis biosensor caspase tracker Nov 15, 2018 Issued
Array ( [id] => 14519493 [patent_doc_number] => 10336994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-02 [patent_title] => Subtilisin variants having a mutation in the S2 or S2# pocket [patent_app_type] => utility [patent_app_number] => 16/193963 [patent_app_country] => US [patent_app_date] => 2018-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 12992 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16193963 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/193963
Subtilisin variants having a mutation in the S2 or S2# pocket Nov 15, 2018 Issued
Array ( [id] => 16298022 [patent_doc_number] => 20200283745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => NUCLEAR-TARGETED DNA REPAIR ENZYMES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/762852 [patent_app_country] => US [patent_app_date] => 2018-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27947 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762852 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/762852
NUCLEAR-TARGETED DNA REPAIR ENZYMES AND METHODS OF USE Nov 13, 2018 Abandoned
Array ( [id] => 14230541 [patent_doc_number] => 20190127443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-02 [patent_title] => MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS [patent_app_type] => utility [patent_app_number] => 16/180456 [patent_app_country] => US [patent_app_date] => 2018-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16180456 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/180456
Multivalent heteromultimer scaffold design and constructs Nov 4, 2018 Issued
Array ( [id] => 14747427 [patent_doc_number] => 20190256887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => Hippo Pathway Bioluminescent Biosensor [patent_app_type] => utility [patent_app_number] => 16/177691 [patent_app_country] => US [patent_app_date] => 2018-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9974 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16177691 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/177691
Hippo pathway bioluminescent biosensor Oct 31, 2018 Issued
Array ( [id] => 16376619 [patent_doc_number] => 20200325461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => Dnase Variants [patent_app_type] => utility [patent_app_number] => 16/757557 [patent_app_country] => US [patent_app_date] => 2018-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69759 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757557 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/757557
DNase variants Oct 25, 2018 Issued
Array ( [id] => 14836231 [patent_doc_number] => 20190276516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => ALPHA1 -ANTITRYPSIN COMPOSITIONS AND METHODS OF TREATING AUTOIMMUNE DISEASES [patent_app_type] => utility [patent_app_number] => 16/166990 [patent_app_country] => US [patent_app_date] => 2018-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15926 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16166990 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/166990
a1-antitrypsin compositions and methods of treating autoimmune diseases Oct 21, 2018 Issued
Array ( [id] => 16261469 [patent_doc_number] => 10752890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-25 [patent_title] => Protease variants and polynucleotides encoding same [patent_app_type] => utility [patent_app_number] => 16/163660 [patent_app_country] => US [patent_app_date] => 2018-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 38577 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16163660 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/163660
Protease variants and polynucleotides encoding same Oct 17, 2018 Issued
Array ( [id] => 14019327 [patent_doc_number] => 20190071657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-07 [patent_title] => Engineered CRISPR-Cas9 Nucleases [patent_app_type] => utility [patent_app_number] => 16/155808 [patent_app_country] => US [patent_app_date] => 2018-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16162 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16155808 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/155808
Engineered CRISPR-Cas9 nucleases Oct 8, 2018 Issued
Array ( [id] => 16893410 [patent_doc_number] => 11034946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-15 [patent_title] => Glycosylation independent proteins [patent_app_type] => utility [patent_app_number] => 16/153371 [patent_app_country] => US [patent_app_date] => 2018-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6480 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16153371 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/153371
Glycosylation independent proteins Oct 4, 2018 Issued
Array ( [id] => 14208833 [patent_doc_number] => 20190116801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-25 [patent_title] => FUSION PROTEINS AND METHODS FOR STIMULATING PLANT GROWTH, PROTECTING PLANTS FROM PATHOGENS, AND IMMOBILIZING BACILLUS SPORES ON PLANT ROOTS [patent_app_type] => utility [patent_app_number] => 16/145628 [patent_app_country] => US [patent_app_date] => 2018-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19127 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16145628 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/145628
Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Sep 27, 2018 Issued
Array ( [id] => 16191149 [patent_doc_number] => 20200231998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => HETEROLOGOUS PRODUCTION OF 10-METHYLSTEARIC ACID BY CELLS EXPRESSING RECOMBINANT METHYLTRANSFERASE [patent_app_type] => utility [patent_app_number] => 16/648117 [patent_app_country] => US [patent_app_date] => 2018-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22359 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648117 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/648117
Heterologous production of 10-methylstearic acid by cells expressing recombinant methyltransferase Sep 19, 2018 Issued
Array ( [id] => 14778689 [patent_doc_number] => 20190264242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-29 [patent_title] => METHODS FOR INCREASING PRODUCT YIELDS [patent_app_type] => utility [patent_app_number] => 16/137264 [patent_app_country] => US [patent_app_date] => 2018-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60120 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16137264 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/137264
METHODS FOR INCREASING PRODUCT YIELDS Sep 19, 2018 Abandoned
Array ( [id] => 14468481 [patent_doc_number] => 20190185883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => CAS9 PROTEINS INCLUDING LIGAND-DEPENDENT INTEINS [patent_app_type] => utility [patent_app_number] => 16/132276 [patent_app_country] => US [patent_app_date] => 2018-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36370 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16132276 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/132276
CAS9 proteins including ligand-dependent inteins Sep 13, 2018 Issued
Array ( [id] => 14231091 [patent_doc_number] => 20190127718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-02 [patent_title] => SUPPRESSION OF CANCER [patent_app_type] => utility [patent_app_number] => 16/126706 [patent_app_country] => US [patent_app_date] => 2018-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29970 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16126706 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/126706
SUPPRESSION OF CANCER Sep 9, 2018 Abandoned
Array ( [id] => 16671411 [patent_doc_number] => 20210060174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-04 [patent_title] => PROTEIN DELIVERY TO MEMBRANES [patent_app_type] => utility [patent_app_number] => 16/644354 [patent_app_country] => US [patent_app_date] => 2018-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19900 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644354 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/644354
Protein delivery to membranes Sep 6, 2018 Issued
Menu